Patent Assignment
Reel/Frame 062475/0509
Change of Address
Recorded: 2023-01-24
Pages: 2
Assignor
SUMITOMO PHARMA CO., LTD.
Executed: 2021-04-01
Assignee
SUMITOMO PHARMA CO., LTD.
6-8, DOSHOMACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Property
(1)
Method of Treating Cancer with an RPN2 Gene Expression Inhibitor
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 15, 2009
From: OCHIYA, TAKAHIRO; KATO, KIKUYA; HONMA, KIMI; UEDA, YASUJI
To: TAISHO PHARMACEUTICAL CO., LTD.; DAINIPPON SUMITOMO PHARMA CO., LTD.; JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CANCER CENTER; KOKEN CO., LTD.
Reel/Frame 022692/0384 →
Change of Name
Nov 4, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 034160/0613 →
Change of Name
Jan 24, 2023
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 063753/0826 →